803 related articles for article (PubMed ID: 19403814)
1. ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1-40) peptides.
Xiong H; Callaghan D; Jones A; Bai J; Rasquinha I; Smith C; Pei K; Walker D; Lue LF; Stanimirovic D; Zhang W
J Neurosci; 2009 Apr; 29(17):5463-75. PubMed ID: 19403814
[TBL] [Abstract][Full Text] [Related]
2. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).
Do TM; Dodacki A; Alata W; Calon F; Nicolic S; Scherrmann JM; Farinotti R; Bourasset F
J Alzheimers Dis; 2016; 49(2):287-300. PubMed ID: 26484906
[TBL] [Abstract][Full Text] [Related]
3. ABCG2- and ABCG4-mediated efflux of amyloid-β peptide 1-40 at the mouse blood-brain barrier.
Do TM; Noel-Hudson MS; Ribes S; Besengez C; Smirnova M; Cisternino S; Buyse M; Calon F; Chimini G; Chacun H; Scherrmann JM; Farinotti R; Bourasset F
J Alzheimers Dis; 2012; 30(1):155-66. PubMed ID: 22391220
[TBL] [Abstract][Full Text] [Related]
4. Blood-Brain Barrier Disruption Increases Amyloid-Related Pathology in TgSwDI Mice.
Abdallah IM; Al-Shami KM; Yang E; Kaddoumi A
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513818
[TBL] [Abstract][Full Text] [Related]
5. Beta-amyloid pathology in human brain microvessel extracts from the parietal cortex: relation with cerebral amyloid angiopathy and Alzheimer's disease.
Bourassa P; Tremblay C; Schneider JA; Bennett DA; Calon F
Acta Neuropathol; 2019 May; 137(5):801-823. PubMed ID: 30729296
[TBL] [Abstract][Full Text] [Related]
6. Intracranial IL-17A overexpression decreases cerebral amyloid angiopathy by upregulation of ABCA1 in an animal model of Alzheimer's disease.
Yang J; Kou J; Lalonde R; Fukuchi KI
Brain Behav Immun; 2017 Oct; 65():262-273. PubMed ID: 28526436
[TBL] [Abstract][Full Text] [Related]
7. ATP-binding cassette transporters P-glycoprotein and breast cancer related protein are reduced in capillary cerebral amyloid angiopathy.
Carrano A; Snkhchyan H; Kooij G; van der Pol S; van Horssen J; Veerhuis R; Hoozemans J; Rozemuller A; de Vries HE
Neurobiol Aging; 2014 Mar; 35(3):565-75. PubMed ID: 24138987
[TBL] [Abstract][Full Text] [Related]
8. Impaired Amyloid Beta Clearance and Brain Microvascular Dysfunction are Present in the Tg-SwDI Mouse Model of Alzheimer's Disease.
Rosas-Hernandez H; Cuevas E; Raymick JB; Robinson BL; Sarkar S
Neuroscience; 2020 Aug; 440():48-55. PubMed ID: 32450297
[TBL] [Abstract][Full Text] [Related]
9. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM
J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340
[TBL] [Abstract][Full Text] [Related]
10. Amyloid-β contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy.
Hartz AM; Bauer B; Soldner EL; Wolf A; Boy S; Backhaus R; Mihaljevic I; Bogdahn U; Klünemann HH; Schuierer G; Schlachetzki F
Stroke; 2012 Feb; 43(2):514-23. PubMed ID: 22116809
[TBL] [Abstract][Full Text] [Related]
11. ABCG2 reduces ROS-mediated toxicity and inflammation: a potential role in Alzheimer's disease.
Shen S; Callaghan D; Juzwik C; Xiong H; Huang P; Zhang W
J Neurochem; 2010 Sep; 114(6):1590-604. PubMed ID: 20626554
[TBL] [Abstract][Full Text] [Related]
12. A shift in microglial β-amyloid binding in Alzheimer's disease is associated with cerebral amyloid angiopathy.
Zabel M; Schrag M; Crofton A; Tung S; Beaufond P; Van Ornam J; Dininni A; Vinters HV; Coppola G; Kirsch WM
Brain Pathol; 2013 Jul; 23(4):390-401. PubMed ID: 23134465
[TBL] [Abstract][Full Text] [Related]
13. Fruquintinib/HMPL-013 ameliorates cognitive impairments and pathology in a mouse model of cerebral amyloid angiopathy (CAA).
Zhou G; Xiang T; Xu Y; He B; Wu L; Zhu G; Xie J; Yao L; Xiao Z
Eur J Pharmacol; 2023 Jan; 939():175446. PubMed ID: 36470443
[TBL] [Abstract][Full Text] [Related]
14. The blood clotting Factor XIIIa forms unique complexes with amyloid-beta (Aβ) and colocalizes with deposited Aβ in cerebral amyloid angiopathy.
de Jager M; Boot MV; Bol JG; Brevé JJ; Jongenelen CA; Drukarch B; Wilhelmus MM
Neuropathol Appl Neurobiol; 2016 Apr; 42(3):255-72. PubMed ID: 25871449
[TBL] [Abstract][Full Text] [Related]
15. Heparanase overexpression impedes perivascular clearance of amyloid-β from murine brain: relevance to Alzheimer's disease.
Zhang X; O'Callaghan P; Li H; Tan Y; Zhang G; Barash U; Wang X; Lannfelt L; Vlodavsky I; Lindahl U; Li JP
Acta Neuropathol Commun; 2021 May; 9(1):84. PubMed ID: 33971986
[TBL] [Abstract][Full Text] [Related]
16. Early-onset formation of parenchymal plaque amyloid abrogates cerebral microvascular amyloid accumulation in transgenic mice.
Xu F; Kotarba AE; Ou-Yang MH; Fu Z; Davis J; Smith SO; Van Nostrand WE
J Biol Chem; 2014 Jun; 289(25):17895-908. PubMed ID: 24828504
[TBL] [Abstract][Full Text] [Related]
17. Long-term voluntary wheel running does not alter vascular amyloid burden but reduces neuroinflammation in the Tg-SwDI mouse model of cerebral amyloid angiopathy.
Robison LS; Popescu DL; Anderson ME; Francis N; Hatfield J; Sullivan JK; Beigelman SI; Xu F; Anderson BJ; Van Nostrand WE; Robinson JK
J Neuroinflammation; 2019 Jul; 16(1):144. PubMed ID: 31296239
[TBL] [Abstract][Full Text] [Related]
18. Endothelial Mitochondrial Dysfunction in Cerebral Amyloid Angiopathy and Alzheimer's Disease.
Parodi-Rullán R; Sone JY; Fossati S
J Alzheimers Dis; 2019; 72(4):1019-1039. PubMed ID: 31306129
[TBL] [Abstract][Full Text] [Related]
19. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.
Bell RD; Zlokovic BV
Acta Neuropathol; 2009 Jul; 118(1):103-13. PubMed ID: 19319544
[TBL] [Abstract][Full Text] [Related]
20. Vascular and parenchymal amyloid pathology in an Alzheimer disease knock-in mouse model: interplay with cerebral blood flow.
Li H; Guo Q; Inoue T; Polito VA; Tabuchi K; Hammer RE; Pautler RG; Taffet GE; Zheng H
Mol Neurodegener; 2014 Aug; 9():28. PubMed ID: 25108425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
